Background: Ascites is a recognized problem in patients with decompensated liver cirrhosis. Spontaneous bacterial peritonitis (SBP) is a massive problem in patients who suffer from cirrhosis with ascites. Early bacterial detection allows great intervention to stop SBP. 16S ribosomal RNA (rRNA) is a universal gene used to detect different bacteria present within a sample. Objectives: This study aimed to evaluate the efficacy of broad range 16S rRNA gene polymerase chain reaction (PCR) in diagnosis of ascitic fluid (AF) infection. Methodology: Fifty cirrhotic ascitic patients were undergone to full history, clinical examination, laboratory tests including, AF specimens analysis for polymorph nuclear leucocytic (PMN) count, culture for bacteria and PCR-for DNA detection of bacteria. Results: Bacteria were separated from 21 (42%) of samples of ascitic fluid, and they were mainly Gram-negative bacteria. The sensitivities of culture for bacteria and PCR in diagnosing AF infection were 53% and 86% respectively, while the accuracies were 62% and 74% respectively relation with PMNL. Conclusions: Bacterial DNA in AF samples may be another method for diagnosis AF infection rather than bacterial culture and PMN count for early detection and treatment of AF infection. METHODOLOGY Patients:This cross-sectional study was conducted in Benha University and National Liver Institute, Menoufia University over the duration from April 2018 to October 2018 and included fifty patients with cirrhosis of liver and ascites. The study was confirmed by the Research Ethical Committee Menoufia University and an informed consent was obtained from each participant before enrollment in the research. The patients in that study with cirrhosis as detected by clinical methods and by laboratory investigations. Exclusion criteria included the presence of any clinical sign of infection and antibiotic intake within the preceding 2 weeks.Patients were classified into 2 groups depending on PMN count into:Group 1(SBP group): it included all cases with ascitic PMN ≥ 250 cells/mm 3 with +ve and -ve culture.Group 2 (Non SBP group): it included all cases with ascitic PMN < 250 cells/mm 3 .
Background: Central Venous Catheter (CVC) use as vascular access to the systemic circulation is highly vital for Hemodialysis (HD) patients. Catheter-related bloodstream infection (CRBSI) is the main complication of CVC use. Aim of the work: To assess the use of surveillance cultures (SCs) to prevent CRBSIs in asymptomatic HD patients. Patients and Methods: A prospective cohort study was conducted on eighteen HD patients with CVC, admitted to Dialysis Units of Benha University Hospitals and Meet Ghamr Nephrology and Urology Hospital during the period from October 2016 to March 2017. Endoluminal colonization of the catheter was assessed every 15 days by inoculating ~5-10 mL of endoluminal blood into aerobic blood culture bottles. Individual patients were triaged based on SC results: group 1 (negative); group 2 (coagulase-negative Staphylococcus [CoNS] with time-topositivity (TTP) >14 hours); group 3 (CoNS with TTP ≤14 hours); and group 4 (any microorganism other than CoNS with any TTP or CoNS with Differential Time to Positivity (DTP) more than 120 minutes). Results: A total of 60 SCs were collected with a mean number per patient of 3.3. Of which 24 SCs (40%) were negative (group 1), and 36 SCs (60%) were positive (0 in group 2, 6 in group 3, and 30 in group 4). Under this protocol, the incidence density of CRBSI was 10.8 episodes per 1000 catheter days. Conclusion: SCs based on easily accessible samples proved useful in triaging HD patients at a high risk of infection.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.